Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Translocation (3;21) characterizes crises in myeloid stem cell disorders.

Z Chen1, R Morgan, M R Baer

  • 1Cancer Center of Southwest Biomedical Research Institute, Scottsdale, Arizona 85251.

Cancer Genetics and Cytogenetics
|December 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cytogenetic and pathologic aspects of Ewing's sarcoma and neuroectodermal tumors.

Human pathology·1992
Same author

Translocation (X;1)(p11.2;q21). A subtype of renal adenocarcinomas.

Cancer genetics and cytogenetics·1992
Same author

Cytogenetic and molecular studies of a familial renal cell carcinoma.

Cancer genetics and cytogenetics·1992
Same author

Cytogenetic and fluorescence in situ hybridization analysis of breast fibroadenomas.

Cancer genetics and cytogenetics·1992
Same author

Application of fluorescence in situ hybridization in hematological disorders.

Cancer genetics and cytogenetics·1992
Same author

Cytogenetic and FISH studies of abnormal X chromosomes in a patient with ANLL.

Cancer genetics and cytogenetics·1992

The translocation t(3;21) was found in patients with chronic myelocytic leukemia (CML) and myelodysplastic syndromes (MDS). This genetic abnormality is associated with myeloid crises and a poor prognosis in these blood disorders.

Area of Science:

  • Hematology
  • Cytogenetics
  • Oncology

Background:

  • Philadelphia chromosome-positive chronic myelocytic leukemia (CML) and primary myelodysplastic syndromes (MDS) are clonal hematopoietic stem cell disorders.
  • Genetic abnormalities play a crucial role in the pathogenesis and prognosis of these hematologic malignancies.

Purpose of the Study:

  • To investigate the occurrence and significance of the t(3;21)(q26;q22) translocation in patients with CML and MDS.
  • To determine the prognostic implications of the t(3;21) abnormality in myeloid crises.

Main Methods:

  • Case study analysis of three patients with myeloid malignancies.
  • Cytogenetic analysis to detect chromosomal abnormalities, specifically t(3;21)(q26;q22).

Main Results:

Related Experiment Videos

  • The t(3;21) translocation was identified in one patient with CML during the blast phase.
  • In two patients with MDS, t(3;21) was observed as the sole abnormality at presentation or during disease progression.
  • The presence of t(3;21) was associated with myeloid crises and indicated a poor prognosis.

Conclusions:

  • The t(3;21) translocation may serve as a marker for myeloid crises in clonal hematopoietic stem cell disorders.
  • This genetic event could be involved in the development of myelodysplasia and subsequent leukemic transformation, suggesting a poor prognosis.